Shu Liao
- Molecular Biology
- Pulmonary and Respiratory Medicine top 5%
- Cancer Research top 5%
- Obstetrics and Gynecology top 2%
- Reproductive Medicine top 2%
- Co-authors
- Mark F. BradyRobert A. BurgerJ.T. ThigpenJohn H. MalfetanoBrent DuBeshterHoward D. HomesleyEric J. StanbridgeRobert A. Figlin
- Topics
- Endometrial and Cervical Cancer Treatments (4 papers)Cervical Cancer and HPV Research (4 papers)Ovarian cancer diagnosis and treatment (3 papers)
- Partner nations
- United StatesChinaSpain
In The Last Decade
Shu Liao
23 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 93
- Molecular Biology 667
- Pulmonary and Respiratory Medicine 458
- Cancer Research 381
- Obstetrics and Gynecology 300
- Reproductive Medicine 271
Countries citing papers authored by Shu Liao
This map shows the geographic impact of Shu Liao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu Liao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu Liao more than expected).
Fields of papers citing papers by Shu Liao
This network shows the impact of papers produced by Shu Liao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu Liao. The network helps show where Shu Liao may publish in the future.
Co-authorship network of co-authors of Shu Liao
This figure shows the co-authorship network connecting the top 25 collaborators of Shu Liao. A scholar is included among the top collaborators of Shu Liao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu Liao. Shu Liao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 2 | |
| 3 | 113 | |
| 4 | 35 | |
| 5 | 15 | |
| 6 | 283 | |
| 7 | 47 | |
| 8 | 28 | |
| 9 | 4 | |
| 10 | 38 | |
| 11 | 20 | |
| 12 | 42 | |
| 13 | 15 | |
| 14 | 21 | |
| 15 | 10 | |
| 16 | 5 | |
| 17 | 7 | |
| 18 | 44 | |
| 19 | Human papillomavirus genotype as a prognostic indicator in carcinoma of the uterine cervix. | 108 |
| 20 | 18 |
About Shu Liao
Shu Liao is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Oncology, having authored 23 papers that have together received 1.4k indexed citations. Recurring topics across this work include Endometrial and Cervical Cancer Treatments (4 papers), Cervical Cancer and HPV Research (4 papers) and Ovarian cancer diagnosis and treatment (3 papers). The work is most often cited by research in Obstetrics and Gynecology (300 citations), Reproductive Medicine (271 citations) and Cancer Research (381 citations). Shu Liao has collaborated with scholars based in United States, China and Spain. Frequent co-authors include Mark F. Brady, Robert A. Burger, J.T. Thigpen, John H. Malfetano, Brent DuBeshter, Howard D. Homesley, Eric J. Stanbridge, Robert A. Figlin, Michael L. Berman and K R Han. Their work appears in journals such as Journal of Clinical Oncology, Cancer and Journal of Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.